Codes / ICD10CM / A81.81

A81.81 Kuru

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Kuru (ICD-10 Code: A81.81)

Summary

Kuru is a rare, fatal neurodegenerative disease that affects the central nervous system. It is characterized by progressive neurological decline, including ataxia, tremors, and cognitive impairment. Kuru is part of the transmissible spongiform encephalopathies (TSEs), a group of disorders caused by prion proteins. The disease primarily affects the cerebellum and other brain regions, leading to spongiform changes in neural tissue.

Causes

Kuru is caused by the transmission of abnormal prion proteins, which induce misfolding of normal cellular prion proteins in the brain. The primary mode of transmission is through ritualistic cannibalism, where infected brain tissue is consumed. This practice was historically common in certain populations in Papua New Guinea. Unlike other prion diseases, kuru is not associated with genetic mutations or sporadic cases.

Risk Factors

  • Participation in ritualistic cannibalistic practices involving brain tissue
  • Residence in or travel to regions with historical exposure to kuru
  • Close contact with individuals who engage in high-risk cultural practices

Symptoms

  • Progressive ataxia (loss of coordination)
  • Tremors and involuntary movements
  • Dysarthria (slurred speech)
  • Muscle weakness
  • Cognitive decline
  • Emotional lability (mood swings)
  • Difficulty swallowing

Diagnosis

Diagnosis of kuru is based on clinical presentation, exposure history, and exclusion of other prion diseases. Neurological examination reveals characteristic signs of cerebellar dysfunction. Imaging studies, such as MRI, may show cerebellar atrophy. Definitive diagnosis requires brain biopsy or postmortem examination to detect prion protein accumulation and spongiform changes.

Treatment Options

There is no cure for kuru, and treatment focuses on managing symptoms. Supportive care includes physical therapy to maintain mobility, speech therapy for communication difficulties, and nutritional support. Medications may be used to alleviate tremors or other movement disorders, but they do not alter disease progression.

Prognosis and Follow-Up

Kuru is invariably fatal, with a median survival time of 12 months after symptom onset. The disease progresses steadily, leading to severe neurological impairment and death. Follow-up care involves regular monitoring of functional status and symptom management to improve quality of life.

Complications

  • Severe ataxia leading to falls and injuries
  • Dysphagia (difficulty swallowing) and aspiration pneumonia
  • Progressive cognitive decline
  • Loss of independence
  • Death

Lifestyle & Prevention

Prevention relies on eliminating exposure to infected brain tissue. Public health measures in affected regions have focused on discontinuing cannibalistic practices. Education and cultural interventions have significantly reduced the incidence of kuru. There are no specific lifestyle modifications for individuals not at risk.

When to Seek Professional Help

Seek medical attention if you experience unexplained neurological symptoms, such as coordination problems, tremors, or cognitive changes, especially if you have a history of exposure to high-risk practices. Early evaluation is critical for ruling out other treatable conditions.

Tips for Medical Coders

When coding for kuru, ensure the documentation supports the diagnosis and exposure history. The code A81.81 is specific to kuru and should be used when the condition is confirmed. Document any relevant cultural or historical context to justify the diagnosis, as this may be required for accurate coding and reimbursement. Avoid using this code for other prion diseases or atypical virus infections.

Book a walkthrough

A81.81 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.